Literature DB >> 8287604

Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activities.

L R Shoemaker1, S J Schurman, V H Donaldson, A E Davis.   

Abstract

The mediator(s) responsible for localized enhanced vascular permeability that characterizes an exacerbation of hereditary angioneurotic oedema (HAE) is thought to be a product of either contact or complement system activation. In contrast to normal individuals, plasma from these patients generates both kinin and vascular permeability-enhancing activity following incubation at 37 degrees C. Depletion of C1 inhibitor in both normal and C2-deficient plasma, but not in contact factor-deficient plasmas, resulted in generation of these activities. The kinin activity from incubated HAE plasma was susceptible to kininase inactivation and was blocked by a Bk2 receptor antagonist. Furthermore, this activity was isolated from HAE plasma; amino acid sequence analysis proved it to be bradykinin. Similarly, the vasopermeability-enhancing activity from ethanol-fractionated or boiled HAE plasma, collected during either attack or remission, co-eluted with bradykinin on reverse-phase high performance liquid chromatography (HPLC). These studies conclusively demonstrate that bradykinin is the major kinin and mediator of enhanced vascular permeability generated during incubation of HAE plasma. The role of other bioactive products, such as the C2 kinin, at local sites of oedema formation remains to be further defined.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8287604      PMCID: PMC1534616          DOI: 10.1111/j.1365-2249.1994.tb06009.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  A permeability factor released from guinea-pig serum by antigen-antibody precipitates.

Authors:  G E DAVIES; J S LOWE
Journal:  Br J Exp Pathol       Date:  1960-08

2.  Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma.

Authors:  V H Donaldson; J Kleniewski; H Saito; J K Sayed
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

3.  Kinin generation in hereditary angioneurotic edema (H.A.N.E.) plasma.

Authors:  V H Donaldson; F S Rosen; D H Bing
Journal:  Adv Exp Med Biol       Date:  1983       Impact factor: 2.622

4.  Alpha 2-macroglobulin-kallikrein complexes detect contact system activation in hereditary angioedema and human sepsis.

Authors:  N Kaufman; J D Page; R A Pixley; R Schein; A H Schmaier; R W Colman
Journal:  Blood       Date:  1991-06-15       Impact factor: 22.113

5.  Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways.

Authors:  R W Colman; A Bagdasarian; R C Talamo; C F Scott; M Seavey; J A Guimaraes; J V Pierce; A P Kaplan
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

6.  Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis.

Authors:  V H Donaldson; H I Glueck; M A Miller; H Z Movat; F Habal
Journal:  J Lab Clin Med       Date:  1976-02

7.  Inhibition of C1s-induced vascular leakage in guinea pigs by substituted benzamidine and pyridinium compounds.

Authors:  J M Andrews; F S Rosen; S J Silverberg; M Cory; E E Schneeberger; D H Bing
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

8.  Purification of subcomponents Clq, Cl(-)r and Cl(-)s of the first component of complement from Cohn Fraction I by affinity chromatography.

Authors:  D H Bing; J M Andrews; K M Morris; E Cole; V Irish
Journal:  Prep Biochem       Date:  1980

9.  Cleavage of the second component of complement by plasma proteases: implications in hereditary C1-inhibitor deficiency.

Authors:  M A Smith; M A Kerr
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

10.  Angioedema induced by a peptide derived from complement component C2.

Authors:  C J Strang; S Cholin; J Spragg; A E Davis; E E Schneeberger; V H Donaldson; F S Rosen
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more
  19 in total

Review 1.  Angioedema associated with C1 inhibitor deficiency.

Authors:  J Laurent; M T Guinnepain
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 8.667

Review 2.  Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.

Authors:  Allen P Kaplan; Kusumam Joseph
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

Review 3.  Autoantibodies in angioneurotic edema.

Authors:  A E Ahmed; J B Peter; Y Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 4.  Bradykinin formation. Plasma and tissue pathways and cellular interactions.

Authors:  A P Kaplan; K Joseph; Y Shibayama; Y Nakazawa; B Ghebrehiwet; S Reddigari; M Silverberg
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

5.  Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor.

Authors:  Eun D Han; Ryan C MacFarlane; Aideen N Mulligan; Jennifer Scafidi; Alvin E Davis
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

Review 6.  C1 inhibitor: molecular and clinical aspects.

Authors:  Marco Cicardi; Lorenza Zingale; Andrea Zanichelli; Emanuela Pappalardo; Benedetta Cicardi
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

Review 7.  Angioedema. Pathogenesis, differential diagnosis, and treatment.

Authors:  Evangelo Frigas; Ugochukwu C Nzeako
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

8.  The pathophysiology of hereditary angioedema.

Authors:  Bruce L Zuraw
Journal:  World Allergy Organ J       Date:  2010-09       Impact factor: 4.084

Review 9.  "Nuts and Bolts" of Laboratory Evaluation of Angioedema.

Authors:  Henriette Farkas; Nóra Veszeli; Erika Kajdácsi; László Cervenak; Lilian Varga
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

Review 10.  Pathophysiology of Hereditary Angioedema.

Authors:  Sonia Caccia; Chiara Suffritti; Marco Cicardi
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2014-12-01       Impact factor: 1.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.